Growing Adoption Of Gene Therapy And RNA Therapies Propelled The Growth In The Global Spinal Muscular Atrophy Market
The treatment includes therapies such as nusinersen and onasemnogen abeparvovec gene therapy that target the underlying genetic causes of SMA. The growing adoption of gene …